Bone Densitometer Market Report by Device Type, Technology (Dual-Energy X-Ray Absorptiometry, Single X-Ray Absorptiometry, Radiographic Absorptiometry, Quantitative Computed Tomography, and Others), Application, End-User, and Region 2024-2032
골밀도계 시장 규모는 2023년 3억 760만 달러에 달했습니다. 향후 IMARC 그룹은 시장이 2032년까지 4억 5,710만 달러에 이를 전망이며, 2024년과 2032년 사이에 4.4%의 복합 연간 성장률(CAGR)을 보일 것으로 예측했습니다.
DXA 장치라고도 불리는 골밀도계는 최소 선량의 전리 방사선을 이용하여 골량과 뼈 부문 내의 칼슘 및 기타 미네랄의 양을 측정하는 장치를 말합니다. DXA 장치에는 중앙 장치와 주변 장치의 두 가지 유형이 있습니다. 중앙 장치는 고관절과 척추의 골밀도를 측정하는 데 사용되며 일반적으로 머리에 팔이있는 평평하고 넓습니다. 한편, 주변 장치는 작고 주로 손목, 발 뒤꿈치, 손가락의 뼈 밀도를 조사하는 데 사용됩니다. 골다공증의 진단에는 특별한 준비가 필요없고, 다른 검사에 비해 비교적 단시간에 끝나기 때문에 표준적인 방법으로 되어 있습니다. 또한 골다공증 골절의 발병 위험을 평가하는데도 사용됩니다.
골밀도계 시장의 주요 추진력 중 하나는 뼈와 관련된 질병에 걸리기 쉬운 노년 인구 증가입니다. 이는 취약성 골절의 발생 건수가 증가함에 따라 시장 성장에 크게 기여하고 있습니다. 이 외에도 이 장비는 골다공증과 골감소증 진단에 매우 중요하기 때문에 여러 병원과 의료 클리닉에서 골밀도 검사에 널리 사용됩니다. DXA 스캐너의 발전으로 보다 빠르고 정확한 진단이 가능해졌으며, 기존 의료 인프라를 개선하기 위한 투자가 증가하고 있는 등, 기타 요인들도 시장 전망을 더욱 밝게 예상됩니다.
이 보고서에서 다루는 주요 질문
- 세계의 골밀도계 시장은 지금까지 어떻게 추이해, 향후 어떻게 추이해 갈 것인가?
- 주요 지역 시장은?
- COVID-19는 세계의 골밀도계 시장에 어떤 영향을 미쳤는가?
- 디바이스 유형별 시장 분석은?
- 기술별 시장 분석은?
- 용도별 시장 분석은?
- 최종 사용자별 시장 분석은?
- 업계의 밸류체인의 다양한 단계란?
- 업계의 주요 촉진요인과 도전은 무엇인가?
- 세계의 골밀도계 시장의 구조와 주요 기업은?
- 업계 경쟁도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 골밀도계 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 디바이스 유형별
제7장 시장 분석 : 기술별
- 이중 에너지 X선 흡수 측정법(DXA)
- 단일 X선 흡수 측정법(SXA)
- 방사선 흡수 측정법(RA)
- 정량적 컴퓨터 단층촬영(QCT)
- 기타
제8장 시장 분석 : 용도별
- 골다공증과 골감소증의 진단
- 낭포성 섬유증의 진단
- 신체 조성 측정
- 류마티스 관절염의 진단
- 기타
제9장 시장 내역 : 최종 사용자별
- 병원과 전문 클리닉
- 진단 및 화상 진단센터
- 기타
제10장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제14장 가격 지표
제15장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Ampall Co. Ltd.
- BeamMed Ltd.
- Diagnostic Medical Systems Group
- Echolight SPA
- GE Healthcare
- Hologic Inc.
- Medonica Co. Ltd.
- Scanflex Healthcare AB
- Swissray Global Healthcare Holding Ltd.
BJH
The global bone densitometer market size reached US$ 307.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 457.1 Million by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.
A bone densitometer, also known as a DXA machine, refers to a device that utilizes a minimal dose of ionizing radiation to measure bone loss and the amount of calcium and other minerals in a bone segment. There are two types of DXA equipment, namely central and peripheral devices. The central devices are used to measure the bone density of the hip and spine, and are usually flat and broad, with an arm overhead. On the other hand, peripheral devices are smaller in size and are mainly used to check bone density in wrists, heels, or fingers. It is the standardized method of diagnosing osteoporosis, as it requires no special preparations and a relatively shorter duration than other procedures. It is also used for assessing an individual's risk for developing osteoporotic fractures.
One of the major drivers of the bone densitometer market is the rise in geriatric population who are highly susceptible to bone-related ailments. This, along with the growing incidents of fragility fracture, is significantly contributing to the market growth. Apart from this, these devices are crucial in diagnosing osteoporosis and osteopenia, owing to which they are widely utilized for bone density testing in several hospitals and healthcare clinics. Other factors, such as advancements in DXA scanners, which have enabled quicker and more accurate diagnosis, along with increasing investments to improve the existing healthcare infrastructure, are expected to further create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone densitometer market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, technology, application and end-user.
Breakup by Device Type:
Axial Bone Densitometers
Peripheral Bone Densitometers
Breakup by Technology:
Dual-Energy X-Ray Absorptiometry (DXA)
Single X-Ray Absorptiometry (SXA)
Radiographic Absorptiometry (RA)
Quantitative Computed Tomography (QCT)
Others
Breakup by Application:
Osteoporosis and Osteopenia Diagnosis
Cystic Fibrosis Diagnosis
Body Composition Measurement
Rheumatoid Arthritis Diagnosis
Others
Breakup by End-User:
Hospitals & Specialty Clinics
Diagnostics and Imaging Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd., etc.
Key Questions Answered in This Report:
- How has the global bone densitometer market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global bone densitometer market?
- What is the breakup of the market based on the device type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global bone densitometer market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bone Densitometer Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Device Type
- 6.1 Axial Bone Densitometers
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Peripheral Bone Densitometers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Dual-Energy X-Ray Absorptiometry (DXA)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Single X-Ray Absorptiometry (SXA)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Radiographic Absorptiometry (RA)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Quantitative Computed Tomography (QCT)
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Application
- 8.1 Osteoporosis and Osteopenia Diagnosis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Cystic Fibrosis Diagnosis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Body Composition Measurement
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Rheumatoid Arthritis Diagnosis
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Hospitals & Specialty Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Diagnostics and Imaging Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Ampall Co. Ltd.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 BeamMed Ltd.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Diagnostic Medical Systems Group
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Echolight S.P.A
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 GE Healthcare
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Hologic Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Medonica Co. Ltd.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Scanflex Healthcare AB
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.9 Swissray Global Healthcare Holding Ltd.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
